Trial ID or NCT#

NCT01586910

Status

NOT RECRUITING

Purpose

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.

Single Arm: The purpose of this trial is to evaluate the safety and effectiveness of transcatheter aortic valve implementation (TAVI) in patients with sever symptomatic Aortic Stenosis (AS) at intermediate surgical risk with TAVI. This is a non-randomized phase of the pivotal clinical trial.

Official Title

Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)

Eligibility Criteria

Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Thomas Burdon
D. Craig Miller, M.D.
Cardiovascular surgeon
Thelma and Henry Doelger Professor in Cardiovascular Surgery
Alan Yeung, MD
Interventional cardiologist, Cardiologist
The Li Ka Shing Professor in Cardiology

Contact us to find out if this trial is right for you.

CONTACT

Leigh Trautman, RN
(650) 725-3931